Fierce Pharma Mix Logo.png Fierce Pharma Mix Logo.png
Webinar

Beyond Protein Counts: Evaluating Depth, Robustness, and Biological Interpretability in Plasma Proteomics

ET
60 Minutes
Human plasma proteomics offers significant potential for biomarker discovery and translational research, but deeper proteome coverage is only part of the challenge. Measurements must also be reproducible, interpretable, and robust to preanalytical variation.
 
In this webinar, a researcher from Roche will present a direct head-to-head evaluation of six plasma proteomics workflows, including Seer Proteograph XT, P2, Mag-Net, ENRICH-iST, Top14 depletion, and neat plasma analysis.
 
The study examines how these workflows compare in proteome depth and reproducibility, and how sample preparation and increasingly stringent plasma processing influence the biological origin and stability of measured protein signals.
 
You will learn about:
  • Why proteome depth should be considered alongside reproducibility and biological interpretability
  • How cellular and vesicular contributions can affect apparent proteome depth
  • Why the secreted plasma proteome remains remarkably stable across processing conditions
  • Why evaluating plasma proteomics technologies requires looking beyond protein counts toward the robustness and biological interpretability of the measurements used to support downstream research decisions

Speakers

0

Prashant Kaushik

Dr. Prashant Kaushik is a Senior Scientist leading proteomic method development for clinical biomarker discovery at Roche Diagnostics in Penzberg, Germany. He brings over six years of post-PhD experience developing scalable LC-MS proteomics solutions across oncology, neurology, and liquid biopsy research. His work focuses on high-throughput biomarker discovery workflows for infectious diseases. Dr. Kaushik earned his Ph.D. from Dublin City University, publishing multi-omics studies on cell signaling networks for biotherapeutic production in CHO cells.

Register here!

Date/Time:
ET